Hospitech Respiration Overview
Hospitech Respiration is a medical-device company focused on the development and commercialization of airway management solutions. The company has developed a platform of solutions aimed at reducing complications related to prolonged mechanical ventilation. Hospitech Respiration has developed the AG100s Automatic Control Unit, a multipurpose airway-management system for automated control of the airway cuff pressure and automated evacuation of subglottic secretions; the AG ETT, a multi-lumen suction endotracheal tube; and the AG CUFFILL, a disposable digital manometer for airway cuff pressure monitoring and managing. The company's products are FDA, CE, and CFDA approved.
Cumulative Funding Raised Over Time ($)
—Aug 2015
Latest News
growth-positive
Hospitech Respiration expands footprint in China's medical market
Israeli MedTech company Hospitech Respiration has partnered with Chinese company AwakeZone to expand its footprint in China. The partnership will establish a wholly-owned subsidiary, Hospitech AwakeZone Medical, to lead production and commercialization of Hospitechs AnapnoGuard device in China. The device is designed to reduce complications in ventilated patients and works alongside ventilators. Hospitech Respiration aims to meet the increasing demand for its airway management devices in China and globally. The company sees China as the worlds second-largest medical device market and plans to work closely with local medical professionals and authorities. This partnership follows a similar deal Hospitech Respiration secured with Medline Industries Inc. in the US.
PartnersExpand
growth-positive
Hospitech Respiration announces partnership with Medline Industries for distributing its AG Cuffill device in the USA
Hospitech Respiration has partnered with Medline Industries for the distribution of the AG Cuffill device, a syringe-like manometer for airways cuff pressure management. Medline will be the exclusive distributor of the device in the United States healthcare markets. The partnership aims to expand the use of the AG Cuffill device and minimize cross-contamination, especially in Covid-19 patients. The partnership allows Hospitech to reach more healthcare and homecare providers across the USA. The AG Cuffill device helps monitor and adjust cuff pressure for intubated patients, reducing the risks and costs associated with improper cuff pressures. The partnership will leverage Medlines sales reps to expand the products presence in hospitals and surgery centers.
Partners
growth-positive
https://www.jpost.com/health-science/israeli-hospitals-using-brand-new-ventilator-to-fight-coronavirus-641169
Three major medical centers in Israel have adopted a new respiratory system called AnapoGuard, produced by Hospitech Respiration, an Israeli startup company. The system helps remove excess fluids in the lungs of coronavirus patients, reducing the risk of lung infections. The hospitals received the devices on a free loan-basis due to the shortage of ventilators. The system has already been in use at the Rambam Medical Center since 2018, and medical experts have welcomed its addition to their arsenal.
Customers
growth-positive
Major healthcare providers in Israel adopt new respiratory guard system amid second COVID-19 wave
Israeli medical device startup Hospitech Respiration has introduced the AnapnoGuard system, a respiratory guard system, to major hospitals in Israel to prevent ventilator-associated complications in COVID-19 patients. The system has been adopted by several hospitals, including the Sheba Medical Centre, Yitzhak Shamir Medical Centre, and Wolfson Medical Centre. AnapnoGuard consists of an automatic control unit and a proprietary multi lumen endotracheal tube, which reduce the likelihood of pulmonary infections and tracheal injury. The introduction of the system is a growth-positive development for Hospitech Respiration.
Customers
growth-positive
With intubated patients on the rise, Israeli innovation aims to prevent ventilator dangers
Israeli MedTech startup, Hospitech Respiration, has developed a respiratory guard system called AnapnoGuard that reduces complications caused by ventilator machines and minimizes exposure of medical staff to infected patients. The company has received FDA, CE, and CFDA approval and has found success with its products, including the AG Cuffill, due to the increase in COVID-19 patients. Hospitech Respiration is looking to expand its outreach in the U.S. to meet the demand for ventilated patients. The AnapnoGuard system and AG Cuffill are expected to become the standard of care in many hospitals.
CustomersExpand
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | Undisclosed |
| Last funding | Undisclosed |
| Stage | Mature |
| Rounds | 1 |
| Investors | 1 |
Team Members
5
Employees: 11-50
Web & Social Links
| Website | www.hospitech.co.il |
Locations
Atir Yeda 15, Kfar Saba, Israel
Photos & Videos
4 item(s)
Hospitech Respiration Business
Business models
B2B
Product stage
Released
Employees
11-50
Sector
Health Tech & Life SciencesMedical DevicesLife SupportTarget Customer
Healthcare & Life SciencesHealthcareProvidersCore Technology
Machinery & RoboticsTags (13)
preventionmonitoringventilationhospitalsreal-timerespiratorymedical-devicesdoctorsclinicshealthcare-providersinfectionhardwarepersonalizationGeographic Markets
EuropeIsraelUnited StatesJapanChinaHospitech Respiration Financials
Undisclosed
Total funding
Undisclosed
Capital raised
Undisclosed
Last funding
Mature
Funding stage
1
Total rounds
1
Investors
Cumulative Funding Raised Over Time ($)
—Aug 2015
Private Equity Funding
A Round
Aug 2015
Undisclosed
Keiretsu Forum Northwest
Hospitech Respiration Lifecycle
Cumulative Funding Raised Over Time
—Aug 2015
All Events
A Round
Aug 2015
Undisclosed
Keiretsu Forum Northwest
Hospitech Respiration News
10 articles
growth-positive
Hospitech Respiration expands footprint in China's medical market
Israeli MedTech company Hospitech Respiration has partnered with Chinese company AwakeZone to expand its footprint in China. The partnership will establish a wholly-owned subsidiary, Hospitech AwakeZone Medical, to lead production and commercialization of Hospitechs AnapnoGuard device in China. The device is designed to reduce complications in ventilated patients and works alongside ventilators. Hospitech Respiration aims to meet the increasing demand for its airway management devices in China and globally. The company sees China as the worlds second-largest medical device market and plans to work closely with local medical professionals and authorities. This partnership follows a similar deal Hospitech Respiration secured with Medline Industries Inc. in the US.
PartnersExpand
growth-positive
Hospitech Respiration announces partnership with Medline Industries for distributing its AG Cuffill device in the USA
Hospitech Respiration has partnered with Medline Industries for the distribution of the AG Cuffill device, a syringe-like manometer for airways cuff pressure management. Medline will be the exclusive distributor of the device in the United States healthcare markets. The partnership aims to expand the use of the AG Cuffill device and minimize cross-contamination, especially in Covid-19 patients. The partnership allows Hospitech to reach more healthcare and homecare providers across the USA. The AG Cuffill device helps monitor and adjust cuff pressure for intubated patients, reducing the risks and costs associated with improper cuff pressures. The partnership will leverage Medlines sales reps to expand the products presence in hospitals and surgery centers.
Partners
growth-positive
https://www.jpost.com/health-science/israeli-hospitals-using-brand-new-ventilator-to-fight-coronavirus-641169
Three major medical centers in Israel have adopted a new respiratory system called AnapoGuard, produced by Hospitech Respiration, an Israeli startup company. The system helps remove excess fluids in the lungs of coronavirus patients, reducing the risk of lung infections. The hospitals received the devices on a free loan-basis due to the shortage of ventilators. The system has already been in use at the Rambam Medical Center since 2018, and medical experts have welcomed its addition to their arsenal.
Customers
growth-positive
Major healthcare providers in Israel adopt new respiratory guard system amid second COVID-19 wave
Israeli medical device startup Hospitech Respiration has introduced the AnapnoGuard system, a respiratory guard system, to major hospitals in Israel to prevent ventilator-associated complications in COVID-19 patients. The system has been adopted by several hospitals, including the Sheba Medical Centre, Yitzhak Shamir Medical Centre, and Wolfson Medical Centre. AnapnoGuard consists of an automatic control unit and a proprietary multi lumen endotracheal tube, which reduce the likelihood of pulmonary infections and tracheal injury. The introduction of the system is a growth-positive development for Hospitech Respiration.
Customers
growth-positive
With intubated patients on the rise, Israeli innovation aims to prevent ventilator dangers
Israeli MedTech startup, Hospitech Respiration, has developed a respiratory guard system called AnapnoGuard that reduces complications caused by ventilator machines and minimizes exposure of medical staff to infected patients. The company has received FDA, CE, and CFDA approval and has found success with its products, including the AG Cuffill, due to the increase in COVID-19 patients. Hospitech Respiration is looking to expand its outreach in the U.S. to meet the demand for ventilated patients. The AnapnoGuard system and AG Cuffill are expected to become the standard of care in many hospitals.
CustomersExpand
growth-positive
Hospitech Respiration's Respiratory Guard System Prevents Complications in Mechanically Ventilated Patients
Israeli medical device company, Hospitech Respiration, has successfully treated over 600 ventilated patients with their respiratory guard system, the AnapnoGuard. The system significantly reduces ventilation complications and minimizes contamination exposure for clinical teams. It has been internationally approved and consists of an automatic control unit and a proprietary multi lumen endotracheal tube. The AnapnoGuard system has been used in China and Israel, including in the treatment of ventilated COVID-19 patients. It has shown a significant reduction in the development of lung and pulmonary infections following intubation. Hospitech Respiration responded to the COVID-19 outbreak by offering their devices pro bono to help medical teams treat ventilated coronavirus patients in Israel. The company expects the ventilator market to increase by 400% in 2020, but also recognizes the negative impact of ventilator-associated complications.
CustomersPartners
growth-positive
https://www.jpost.com/health-science/israeli-startup-protects-coronavirus-intubate-patients-from-complications-624552
Israeli startup Hospitech Respiration is helping protect coronavirus intubate patients from complications caused by prolonged ventilator use. The companys technology ensures effective sealing of the trachea, preventing leakage of secretions and reducing the risk of Ventilator Associated Pneumonia (VAP). Hospitechs devices were used in the treatment of coronavirus patients in China, and the companys newest device, AnapnoGuard, has been adopted by five hospitals in Israel to help with the crisis. The company is providing the devices for free to assist during the emergency. Feedback from medical teams has been positive, as the technology reduces exposure to infected patients and decreases workload.
Customers
growth-positive
Device preventing ventilator complications offered to Israeli hospitals free of charge during COVID-19 pandemic
Hospitech Respiration, an Israeli startup, is offering their AnapnoGuard device AG100s for free to Israeli hospitals battling the coronavirus. The device is designed to prevent health complications caused by ventilator usage and has regulatory approval in multiple countries. It is already used in ICUs and clinics specializing in cardiac support and organ transplants. The company aims to reduce complications and injuries caused by ventilation, especially those arising from the aspiration of contaminated secretions to the lungs. The device is also intended to reduce mechanical damage and injuries to the tracheal wall. With the COVID-19 outbreak, Hospitech Respiration is providing the devices and support to ICUs treating ventilated coronavirus patients.
Customers
growth-positive
Novel Airway Management System by Hospitech, Reduces Ventilation Complications in Lung Transplantation
Hospitech Respiration announced that a new article was recently published by physicians from Mayo Clinic, FL, USA, describing the successful use of the AnapnoGuard system in postoperative management of lung transplant patients. The article highlights the potential of the AnapnoGuard system to reduce complications in mechanically ventilated patients, particularly in high-risk populations. The company looks forward to generating further supporting data as the use of the AnapnoGuard system expands in the USA and Europe.
Customers
Hospitech Respiration Ltd. Announced Clearance of a 510(k) Pre-Market Notification for the AnapnoGuard System
Hospitech Respiration Team
Employee Info
| Employees (range) | 11-50 |
| Exact count | 23 |
| Team members | 5 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
This entity has 7 classification IDs that could be used for matching.
Hospitech Respiration Internal
Recent Updates
No update log entries.
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 99/100 |
| Missing | markets |
| BI Verification | Yanina Wainscheinker |
| Registrar ID | 513814939 |
| Crunchbase | hospitech |
| Phone | +97239191648 |
| Last updater | Yanina Wainscheinker |
| Updater email | yanina.wain@gmail.com |
| Last update | 2020-12-11T00:00:00.000Z |
| Created | 2014-11-24T00:00:00.000Z |
| Claimed | Yes |